UTHR
United Therapeutics CorpstockNASDAQ
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of "medicines for life" and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 595.66 | 2026-11-11 | -3.04% | 0.127 |
| 1M | 543.15 | 2026-10-19 | +6.33% | 1.032 |
| 3M | 518.27 | 2026-08-18 | +11.44% | 0.701 |
| 6M | 566.99 | 2026-05-18 | +1.86% | 0.283 |
| 1Y | 476.59 | 2025-11-18 | +21.18% | 0.432 |
| 2Y | 359.21 | 2024-11-18 | +60.78% | — |
| 5Y | 202.61 | 2021-11-18 | +185.06% | 0.406 |
United Therapeutics Corp (NASDAQ:UTHR) stock price today is $577.55, and today's volume is 433,871. UTHR is down 1.121% today. The 30 day average volume is 596,874. UTHR market cap is $24.60B with 42.59M shares outstanding.
